Tango Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TNGX research report →
Companywww.tangotx.com
Tango Therapeutics, Inc. , a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions.
- CEO
- Malte Peters
- IPO
- 2020
- Employees
- 155
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $2.45B
- P/E
- -28.18
- P/S
- 42.91
- P/B
- 7.72
- EV/EBITDA
- -20.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 97.25%
- Op Margin
- -206.22%
- Net Margin
- -188.15%
- ROE
- -41.54%
- ROIC
- -27.69%
Growth & Income
- Revenue
- $62.38M · 48.29%
- Net Income
- $-101,594,000 · 22.03%
- EPS
- $-0.87 · 26.89%
- Op Income
- $-111,289,000
- FCF YoY
- -5.81%
Performance & Tape
- 52W High
- $28.41
- 52W Low
- $1.72
- 50D MA
- $21.83
- 200D MA
- $12.40
- Beta
- 1.22
- Avg Volume
- 3.47M
Get TickerSpark's AI analysis on TNGX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Crystal Adam | other | 27,000 |
| May 1, 26 | Crystal Adam | other | 27,000 |
| May 1, 26 | Crystal Adam | sell | 25,900 |
| May 1, 26 | Crystal Adam | sell | 1,100 |
| May 1, 26 | Gall Matthew | other | 240,000 |
| May 1, 26 | Gall Matthew | other | 40,000 |
| Apr 29, 26 | Lee Sung | other | 12,300 |
| Apr 29, 26 | Lee Sung | other | 5,200 |
| Apr 15, 26 | Newcomb Jessica | other | 0 |
| Apr 15, 26 | Newcomb Jessica | other | 153,094 |
Our TNGX Coverage
We haven't published any research on TNGX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TNGX Report →